Posted in | News | Laser | Display | Medical Optics

Palomar Unveils Latest Innovation in Aesthetic Laser Technology

Palomar Medical Technologies Inc., a leading researcher and developer of light- based systems for cosmetic treatments, announced today that it will unveil its latest innovation in aesthetic laser technology at the 28th annual conference of the American Society for Laser Medicine + Surgery (ASLMS) in Kissimmee Florida, April 2-6.

Palomar will display a new platform called the Aspire(TM) aesthetic laser platform and Stylus(TM) Sculpter laser-assisted liposuction handpiece in booth #507 in the ASLMS exhibit hall. The Aspire platform will allow Palomar to offer solutions to new procedures which are in high-demand including laser-assisted liposuction. The Aspire platform will complement the broad range of aesthetic applications offered by Palomar's flagship StarLux(R) 500 laser and pulsed-light platform.

Traditional liposuction is one of the most commonly performed plastic surgery procedures, according to the 2007 survey from the American Society of Aesthetic Plastic Surgery. Laser-assisted liposuction holds out the promise for a better technique due to the laser's ability to quickly and selectively melt fat and heat surrounding tissue. Palomar's approach to laser-assisted liposuction with the Aspire platform and Stylus Sculpter handpiece is to utilize unique tip designs and selective and efficient wavelengths for melting fat and providing the desired thermal effects on surrounding tissue.

Chief Executive Officer Joseph P. Caruso commented, "The unveiling of the Aspire platform and Stylus Sculpter handpiece is the culmination of years of research directed to absorption of light by fat. Our system uses optimal wavelengths to melt fat and provide the appropriate amount of heat to the surrounding tissue. As with all Palomar products, the Aspire platform is based on sound scientific principles developed and tested by Palomar's research and development organization, which is preeminent in the light-based aesthetic industry."

Mr. Caruso continued, "The Aspire platform is an ideal complement to the StarLux platform for providing opportunities for even more treatment modalities. With the new aesthetic procedures that will be possible with Aspire, and the many popular treatments, including hair removal, skin rejuvenation and skin resurfacing, available with the StarLux(R) 500, practitioners will be able to offer a complete suite of the most-requested aesthetic procedures."

The Aspire Platform and Stylus Sculpter liposuction laser-assisted handpiece are pending FDA clearance and should be available for shipment in the third quarter.

In addition to the introduction of the Aspire platform, the following presentations at ASLMS are relevant to Palomar technology:

April 4, 2008 -- Randomized Study of Intense Pulsed Light and Pulsed Dye Laser in the Treatment of Facial Telangiectasia. 2:24 pm - 2:29 pm (The Sun AB Room) -- Long-Term Experience with Fixed Array 1540 Fractional Erbium Laser for Acne Scars. 3:54 pm - 3:59 pm (The Sun AB Room) -- Ablative Micro-Fractional Resurfacing: Time-Course Histology and Clinical Correlations. 4:23 pm - 4:28 pm (The Sun AB Room) -- Use of a Micro-Fractional 2940 NM Laser in the Treatment of Wrinkles and Dyspigmentation. 5:12 pm - 5:17 pm (The Grapevine B Room)

April 5, 2008 -- Self Canalization of Laser Microbeam in Tissue as Fundamental Mechanism of Fractional Skin Resurfacing. 4:51 pm - 4:58 pm (The Sun AB Room)

April 6, 2008 -- Deep Infrared Light for Skin Tightening Combined with 1540NM Fractional Resurfacing -- Split-Face Study. 8:20 am - 8:25 am (The Sun AB Room)

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.